Clinical and genomic characterization of metastatic small cell/neuroendocrine prostate cancer (SCNC) and intermediate atypical prostate cancer (IAC): Results from the SU2C/PCF/AACRWest Coast Prostate Cancer Dream Team (WCDT).
2016 ◽
Vol 34
(15_suppl)
◽
pp. 5019-5019
◽
Keyword(s):
Keyword(s):
2021 ◽
2019 ◽
Vol 26
(7)
◽
pp. 1667-1677
◽
Keyword(s):
2015 ◽
Vol 22
(6)
◽
pp. 1510-1519
◽